These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 28938693)

  • 1. The regulation of immune cells by Lactobacilli: a potential therapeutic target for anti-atherosclerosis therapy.
    Ding YH; Qian LY; Pang J; Lin JY; Xu Q; Wang LH; Huang DS; Zou H
    Oncotarget; 2017 Aug; 8(35):59915-59928. PubMed ID: 28938693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune-Inflammatory Responses in Atherosclerosis: The Role of Myeloid Cells.
    Chistiakov DA; Kashirskikh DA; Khotina VA; Grechko AV; Orekhov AN
    J Clin Med; 2019 Oct; 8(11):. PubMed ID: 31717832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of Th1/Th2 balance by Lactobacillus strains isolated from Kimchi via stimulation of macrophage cell line J774A.1 in vitro.
    Won TJ; Kim B; Song DS; Lim YT; Oh ES; Lee DI; Park ES; Min H; Park SY; Hwang KW
    J Food Sci; 2011 Mar; 76(2):H55-61. PubMed ID: 21535768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conversion of human M-CSF macrophages into foam cells reduces their proinflammatory responses to classical M1-polarizing activation.
    da Silva RF; Lappalainen J; Lee-Rueckert M; Kovanen PT
    Atherosclerosis; 2016 May; 248():170-8. PubMed ID: 27038418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypercholesterolemia is associated with a T helper (Th) 1/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice.
    Zhou X; Paulsson G; Stemme S; Hansson GK
    J Clin Invest; 1998 Apr; 101(8):1717-25. PubMed ID: 9541503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treating atherosclerosis with regulatory T cells.
    Foks AC; Lichtman AH; Kuiper J
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):280-7. PubMed ID: 25414253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probiotic bacterial strains differentially modulate macrophage cytokine production in a strain-dependent and cell subset-specific manner.
    Habil N; Al-Murrani W; Beal J; Foey AD
    Benef Microbes; 2011 Dec; 2(4):283-93. PubMed ID: 22146688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioinformatics approach to evaluate differential gene expression of M1/M2 macrophage phenotypes and antioxidant genes in atherosclerosis.
    da Rocha RF; De Bastiani MA; Klamt F
    Cell Biochem Biophys; 2014 Nov; 70(2):831-9. PubMed ID: 24771407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Helper T cells and atherosclerosis: the cytokine web.
    Baidya SG; Zeng QT
    Postgrad Med J; 2005 Dec; 81(962):746-52. PubMed ID: 16344296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effects of six probiotic strains on immune function in vitro.
    Dong H; Rowland I; Yaqoob P
    Br J Nutr; 2012 Aug; 108(3):459-70. PubMed ID: 22054064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4+ T cells in atherosclerosis: regulation by platelets.
    Li N
    Thromb Haemost; 2013 Jun; 109(6):980-90. PubMed ID: 23446374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of strong interleukin-10 inducing lactic acid bacteria which down-regulate T helper type 2 cytokines.
    Niers LE; Timmerman HM; Rijkers GT; van Bleek GM; van Uden NO; Knol EF; Kapsenberg ML; Kimpen JL; Hoekstra MO
    Clin Exp Allergy; 2005 Nov; 35(11):1481-9. PubMed ID: 16297146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances on CD4
    Grönberg C; Nilsson J; Wigren M
    Eur J Pharmacol; 2017 Dec; 816():58-66. PubMed ID: 28457923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. STAT4 deficiency reduces the development of atherosclerosis in mice.
    Taghavie-Moghadam PL; Gjurich BN; Jabeen R; Krishnamurthy P; Kaplan MH; Dobrian AD; Nadler JL; Galkina EV
    Atherosclerosis; 2015 Nov; 243(1):169-78. PubMed ID: 26386214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of autophagy ameliorates atherogenic inflammation by augmenting apigenin-induced macrophage apoptosis.
    Wang Q; Zeng P; Liu Y; Wen G; Fu X; Sun X
    Int Immunopharmacol; 2015 Jul; 27(1):24-31. PubMed ID: 25899084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An unexpected intriguing effect of Toll-like receptor regulator RP105 (CD180) on atherosclerosis formation with alterations on B-cell activation.
    Karper JC; de Jager SC; Ewing MM; de Vries MR; Bot I; van Santbrink PJ; Redeker A; Mallat Z; Binder CJ; Arens R; Jukema JW; Kuiper J; Quax PH
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2810-7. PubMed ID: 24115036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pentacyclic triterpene Lupeol switches M1 macrophages to M2 and ameliorates experimental inflammatory bowel disease.
    Zhu Y; Li X; Chen J; Chen T; Shi Z; Lei M; Zhang Y; Bai P; Li Y; Fei X
    Int Immunopharmacol; 2016 Jan; 30():74-84. PubMed ID: 26655877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage phenotypes in atherosclerosis.
    Colin S; Chinetti-Gbaguidi G; Staels B
    Immunol Rev; 2014 Nov; 262(1):153-66. PubMed ID: 25319333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell subsets and functions in atherosclerosis.
    Saigusa R; Winkels H; Ley K
    Nat Rev Cardiol; 2020 Jul; 17(7):387-401. PubMed ID: 32203286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral administration of taheebo (Tabebuia avellanedae Lorentz ex Griseb.) water extract prevents DSS-induced colitis in mice by up-regulating type II T helper immune responses.
    Park HJ; Lee SW; Kwon DJ; Heo SI; Park SH; Kim SY; Hong S
    BMC Complement Altern Med; 2017 Sep; 17(1):448. PubMed ID: 28877696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.